URB602 ([1,1′-biphenyl]-3-yl-carbamic acid, cyclohexyl ester) is a compound that has been found to inhibit hydrolysis of monoacyl glycerol compounds, such as 2-arachidonoylglycerol (2-AG) and 2-oleoylglycerol (2-OG). It was first described in 2003. A study performed in 2005 found that the compound had specificity for metabolizing 2-AG over anandamide (another cannabinoid ligand) in rat brain presumably by inhibiting the enzyme monoacylglycerol lipase (MAGL), which is the primary metabolic enzyme of 2-AG.
IUPAC name: Cyclohexyl [1,1′-biphenyl]-3-ylcarbamate
Other name: [1,1′-Biphenyl]-3-yl-carbamic acid, cyclohexyl ester
CAS number: 565460-15-3
Purity: 99,9% min
Appearance: white powder
The physiological and toxicological properties of this compound are not known. This product is intended for research and forensic purposes.